COVID-19 vaccine being developed by AstraZeneca Plc and Oxford University for use in the United States ahead of the November 3 elections, the Financial Times reported.One option being explored would involve the U.S.
Food and Drug Administration (FDA) awarding "emergency use authorization" in October to the potential vaccine, which was developed by Oxford and licensed to AstraZeneca, the FT reported.AstraZeneca denied having discussed an emergency use authorization for its potential vaccine with the U.S.
government."AstraZeneca has not discussed emergency use authorization with the U.S. government and it would be premature to speculate on that possibility," a spokeswoman for AstraZeneca said in a statement.The company said that the.